ArticleThe journal of allergy and clinical immunology. In practice2021

The Importance of a Timely Second Dose of the 2021 COVID-19 mRNA Vaccine Depends on the Protection Afforded by a First Dose and Subsequent Risk of Anaphylaxis.

Marcus Shaker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.